Propanc Biopharma CEO attends University of Granada keynote on rejuvenation science
PUBT · 06/02 09:30
Share
Listen to the news
- Propanc CEO James Nathanielsz attended a University of Granada keynote on rejuvenation science in Granada, Spain.
- He highlighted Propanc’s proenzyme research with Granada and Jaén universities as PRP targets a Phase 1b first-in-human trial in advanced cancer.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020530PRIMZONEFULLFEED9729304) on June 02, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending